Target community

  • Patients with disorders of platelet number and function including autoimmune diseases, immuno- deficiency and unexplained bleeding
  • Clinicians and GPs
  • Medical students
  • Pharmaceutical industry
  • Government departments involved in the development of health policy

Updated:  31 October 2018/Responsible Officer:  Director, JCSMR/Page Contact:  Web Manager